AVITA Medical (AVHHL) Depreciation & Amortization (CF) (2019 - 2025)

AVITA Medical has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $700000.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 71.15% year-over-year to $700000.0; the trailing twelve-month figure through Dec 2025 stood at $2.3 million (up 108.44% YoY), and the FY2025 full-year result was $2.3 million, up 108.44% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $700000.0, up from $574000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $700000.0 in Q4 2025, with the low at $130000.0 in Q3 2022.
• Historically, Depreciation & Amortization (CF) has averaged $289555.6 across 5 years, with a median of $195000.0 in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) retreated 25.29% — and 2025, when it surged 170.59%.
• AVITA Medical's Depreciation & Amortization (CF) stood at $174000.0 in 2021, then dropped by 25.29% to $130000.0 in 2022, then jumped by 43.85% to $187000.0 in 2023, then soared by 118.72% to $409000.0 in 2024, then jumped by 71.15% to $700000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $700000.0 (Q4 2025), $574000.0 (Q3 2025), and $552000.0 (Q2 2025), per Business Quant data.